Cosmos Health Inc.

Cosmos Health Inc. is a diversified, vertically integrated global healthcare group headquartered in Chicago, Illinois, USA. Incorporated in 2009, the company's core mission is to make high-quality healthcare accessible worldwide by driving innovation at the intersection of science, technology, and digital finance. It operates through subsidiaries specializing in the wholesale distribution of pharmaceutical products across Europe and is actively engaged in the nutraceuticals sector.

The company's product portfolio includes proprietary nutraceutical brands such as "Sky Premium Life" and "Mediterranation," alongside a broad range of branded over-the-counter (OTC) drugs, branded generics, and other medical products. Through its subsidiary Cana Laboratories S.A., Cosmos Health manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The group also focuses on research and development (R&D) of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products, and has expanded into telehealth services via its acquisition of ZipDoctor, Inc.

Led by CEO Greg Siokas, Cosmos Health Inc. reported record full-year 2025 revenue of $65.3 million. Recent strategic initiatives include a significant expansion into the U.S. market with new nutraceutical platforms like the "18 Series," Cur18, and Liv18, which are projected to generate substantial annual revenues. The company is also investing in artificial intelligence to enhance operational efficiency and is pursuing a digital asset strategy, including managing a $300 million treasury facility.